JHSOX | VEXRX | JHSOX / VEXRX | |
Total Expense Ratio | 0.96 | 0.33 | 291% |
Annual Report Gross Expense Ratio | 0.97 | 0.33 | 294% |
Fund Existence | 10 years | 24 years | - |
Gain YTD | -6.231 | -4.539 | 137% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250000 | 50000 | 500% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 265M | 19.4B | 1% |
Annual Yield % from dividends | 0.00 | 0.54 | - |
Returns for 1 year | 0.65 | -4.58 | -14% |
Returns for 3 years | 6.29 | 16.73 | 38% |
Returns for 5 years | 13.31 | 12.41 | 107% |
Returns for 10 years | -9.83 | 8.95 | -110% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HQITX | 21.10 | -0.16 | -0.75% |
Hartford Equity Income R5 | |||
UGMVX | 11.50 | -0.16 | -1.37% |
Victory Global Managed Volatility | |||
GSPCX | 13.65 | -0.19 | -1.37% |
Goldman Sachs Large Cap Equity C | |||
TMCAX | 11.65 | -0.19 | -1.60% |
RBC SMID Cap Growth A | |||
PHPSX | 18.77 | -0.39 | -2.04% |
ProFunds Pharmaceuticals UltraSector Svc |